wada350.JPG

Hiroshi Wada, M.D., Ph.D.

Radiation Oncologist
Deputy Director, Southern TOHOKU Proton Beam Therapy Center

  • Present Title & Affiliation

    • Deputy Director, Southern TOHOKU Proton Beam Therapy Center, Japan

  • Education

    • 1999 M.D.

      Tohoku University School of Medicine, Japan

    • 2003 Ph.D.

      Tohoku University Graduate School of Medicine, Japan

       

  • Certifications

    • 1997

      Board-certified Radiologist by Japan Radiological Society (JRS)

       

    • 1998

      Board-certified Radiation Oncologist by Japanese Society for Radiation Oncology (JASTRO)

  • Professional Experience

    • 1990-1993

       

      Resident, Nagai Municipal General Hospital (presently integrated as a satellite facility to Okitama Public General Hospital), Japan

    • 1993-1995

      Lecturer, Dept. of Radiology, Tohoku University School of Medicine, Japan

    • 1995-1997

      Physician, Dept. of Radiology, Iwaki Municipal General Hospital (renamed as Iwaki City Medical Center), Japan

    • 1997-1999

      Senior Lecturer, Dept. of Radiology, Tohoku University School of Medicine, Japan

    • 1999-2002

      Associate Specialist, Dept. of Radiology, Takeda General Hospital, Japan

    • 2002-2004

      Associate Specialist, Dept. of Radiology, Yamagata City Hospital SAIZEIKAN, Japan

    • 2004-2005

      Senior Lecturer, Dept. of Radiology, Yamagata University Faculty of Medicine, Japan

    • 2005-2006

      Associate Professor, Dept. of Radiology, Yamagata University Faculty of Medicine, Japan

    • 2006-2011

      Associate Professor, Dept. of Radiology, Division of Radiation Oncology, Yamagata University Faculty of Medicine, Japan

    • 2008-2011

      Associate Professor, Dept. of Future Medical Science of Cancer in Tohoku Region, Yamagata University Faculty of Medicine, Japan

    • 2011-2015

      Director, Dept. of Radiation Oncology, Miyagi Cancer Center, Japan

    • 2015-2018

      Clinic Director, Southern TOHOKU Proton Beam Therapy Center, Japan

    • 2018-present

      Deputy Director, Southern TOHOKU Proton Beam Therapy Center, Japan

  • Skill Highlights

    • Radiation Oncology
    • Proton Beam Therapy for cancers

  • Professional Memberships

    • Japan Radiological Society (JRS)
    • Japanese Society for Radiation Oncology (JASTRO)
    • Japanese Society for Palliative Medicine (JSPM)

  • Selected Publications

    • Wada H, Nemoto K, Nomiya T, Muramkami M, Suzuki M, Kuroda Y, Ichikawa M, Ota I, Hagiwara Y, Ariga H, Takeda K, Takai K, Fujimoto K, Kenjo M, Ogawa K. A phase I trial of S-1 with concurrent radiotherapy in patients with locally recurrent rectal cancer. Int J Clin Oncol 2013; 18(2): 273-8
    • Wada H, Nemoto K, Ogawa Y, Hareyama M, Yoshida H, Takamura A, Ohmori K, Hamamoto Y, Sugita T, Saitoh M, Yamada S. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan. Int J Radiat Oncol Biol Phys 2004; 59(2): 495-500
    • Wada H, Takai Y, Nemoto K, Yamada S. Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors. Int J Radiat Oncol Biol Phys 2004; 58(4): 1114-20
    • Ono T, Hareyama M, Nakamura T, Kimura K, Hayashi Y, Azami Y, Hirose K, Hatayama Y, Suzuki M, Wada H, Kikuchi Y, Nemoto K. The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis: a single center experience. Radiat Oncol 2016; 11: 56
    • Hatayama Y, Nakamura T, Suzuki M, Azami Y, Ono T, Yabuuchi T, Hayashi Y, Kimura K, Hirose K, Wada H, Hareyama M, Kikuchi Y, Takai Y. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer. Clin Lung Cancer 2016; 17(5): 427-432
    • Kosugi T, Shikama N, Saito T, Nakamura N, Nakura A, Harada H, Wada H, Nozaki M, Uchida N, Nakamura K. A Nationwide Survey in Japan of Palliative Radiotherapy for Bleeding in Gastrointestinal and Genitourinary Tumor Patients World J Oncol. 2016; 7(2-3): 29-33
    • Hayashi Y, Nakamura T, Mitsudo K, Kimura K, Yamaguchi H, Ono T, Azami Y, Takayama K, Hirose K, Yabuuchi T, Suzuki M, Hatayama Y, Kikuchi Y, Wada H, Fuwa N, Hareyama M, Tohnai I. Re-irradiation using proton beam therapy combined with weekly intra-arterial chemotherapy for recurrent oral cancer. Asia Pac J Clin Oncol 2016 May 25
    • Ariga T, Toita T, Kato S, Kazumoto T, Kubozono M, Tokumaru S, Eto H, Nishimura T, Niibe Y, Nakata K, Kaneyasu Y, Nonoshita T, Uno T, Ohno T, Iwata H, Harima Y, Wada H, Yoshida K, Gomi H, Numasaki H, Teshima T, Yamada S, Nakano T. Treatment outcomes of patients with FIGO Stage I/II uterine cervical cancer treated with definitive radiotherapy: a multi-institutional retrospective research study. J Radiat Res 2015; 56(5): 841-8
    • Imai T, Matsuura K, Asada Y, Sagai S, Katagiri K, Ishida E, Saito D, Sadayasu R, Wada H, Saijo S. Effect of HMB/Arg/Gln on the prevention of radiation dermatitis in head and neck cancer patients treated with concurrent chemoradiotherapy. Jpn J Clin Oncol 2014; 44(5): 422-7
    • Nakamura N., Shikama N., Wada H., Harada H., Nozaki M., Nagakura H., Tago M., Oguchi M., Uchida N. and the Japanese Radiation Oncology Study Group Working Subgroup of Palliative Radiotherapy. Patterns of Practice in Palliative Radiotherapy for Painful Bone Metastases: A Survey in Japan. Int J Radiat Oncol Biol Phys 2012; 83: e117-20
    • Ogawa K., Karasawa K., Ito Y., Ogawa Y., Jingu K., Onishi H., Aoki S., Wada H., Kokubo M., Ogo E., Etoh H., Kazumoto T., Takayama M., Nemoto K., and Nishimura Y. ：JROSG Working Subgroup of Gastrointestinal Cancers. Intraoperative radiotherapy for unresectable pancreatic cancer: a multi-institutional retrospective analysis of 144 patients. Int J Radiat Oncol Biol Phys 2011; 80: 111-118
    • Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Etoh H, Kazumoto T, Takayama M, Negoro Y, Nemoto K, Nishimura Y; JROSG Working Subgroup of Gastrointestinal Cancers. Intraoperative radiotherapy for resected pancreatic cancer: a multi-institutional retrospective analysis of 210 patients. Int J Radiat Oncol Biol Phys 2010; 77(3): 734-42
    • Nomiya T, Teruyama K, Wada H, Nemoto K. Time course of pain relief in patients treated with radiotherapy for cancer pain: a prospective study. Clin J Pain 2010; 26(1): 38-42
    • Nomiya T, Nemoto K, Wada H, Takai Y, Yamada S Long-Term Results of Radiotherapy for T1a and T1bN0M0 Glottic Carcinoma Laryngoscope 2008; 118: 1417-1421
    • Nomiya T, Teruyama K, Wada H, Nemoto K. Chemoradiotherapy for a patient with a giant esophageal fistula. World J Gastroenterol 2007; 13(15): 2250-4
    • Nomiya T, Nemoto K, Wada H, Takai Y, Yamada S. Advantage of accelerated fractionation regimens in definitive radiotherapy for stage II glottic carcinoma. Ann Otol Rhinol Laryngol 2006; 115(10): 727-32
    • Nemoto K, Takai K, Ogawa Y, Sakayauchi T, Sugawara T, Jingu K, Wada H, Takai Y, Yamada S. Salvage radiation therapy for residual superficial esophageal cancer after endoscopic mucosal resection. Int J Radiat Oncol Biol Phys 2005; 63(5): 1290-4
    • Nemoto K, Takai Y, Ogawa Y, Kakuto Y, Ariga H, Matsushita H, Wada H, Yamada S Fetal hemorrhage in irradiated esophageal cancer patients. Acta Oncol 37: 259-262, 1998
Back
Printer Friendly